Calidi Biotherapeutics Inc (CLDI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Operating Expenses | 7,221 | 6,537 | 5,414 | 15,297 | 6,986 |
| Operating Income | -7,221 | -6,537 | -5,414 | -15,252 | -6,986 |
| Interest Expense | 324 | 306 | 217 | 129 | 29 |
| Other Income | 5,532 | -5,654 | -827 | -10,305 | 1,661 |
| Pre-tax Income | -2,013 | -12,497 | -6,458 | -25,685 | -5,354 |
| Income Tax | 11 | 4 | 4 | 10 | 1 |
| Net Income Continuous | -2,024 | -12,501 | -6,462 | -25,695 | -5,355 |
| Net Income | $-2,024 | $-12,501 | $-6,462 | $-25,695 | $-5,355 |
| EPS Basic Total Ops | -16.93 | -170.95 | -90.04 | -306.12 | -75.63 |
| EPS Basic Continuous Ops | -16.98 | -170.92 | -89.63 | -401.26 | -75.05 |
| EPS Diluted Total Ops | -16.93 | -170.95 | -90.04 | -306.12 | -75.63 |
| EPS Diluted Continuous Ops | -16.98 | -170.92 | -89.63 | -401.26 | -75.05 |
| EBITDA(a) | $-6,675 | $-5,864 | $-5,030 | $-15,096 | $-6,986 |